Mersana Therapeutics (MRSN) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.61
-0.44
-0.26
-0.09

Details

Expected EPS
-0.44
Actual EPS
-0.52
Surprise EPS
-0.08
Surprise Percent
+18.18%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.52 per share for Q1 2023.

0 Comments

Share your thoughts